Evidence map›Paper›PMID 39122676›Full record

ArticleNature communications2024

Atypical and non-classical CD45RB

David G Priest, Takeshi Ebihara, Janyerkye Tulyeu, Jonas N Søndergaard, Shuhei Sakakibara, Fuminori Sugihara, Shunichiro Nakao, Yuki Togami, Jumpei Yoshimura, Hiroshi Ito and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Targeting T follicular helper cells for lifelong health.Nature reviews. Drug discovery · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Towards personalized vaccines.Frontiers in immunology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

David G PriestLaboratory of Human Single Cell Immunology, World Premier International Research Center Initiative Immunology Frontier Research Center (WPI-IFReC), Osaka University, Suita, Osaka, 563-0793, Japan.ORCID 0000-0003-0095-6718
Takeshi EbiharaCenter for Infectious Disease Education and Research (CiDER), Osaka University, Suita, Osaka, 565-0871, Japan.
Janyerkye TulyeuHuman Single Cell Immunology Team, Center for Infectious Disease Education and Research (CiDER), Osaka University, Suita, Osaka, 565-0871, Japan.ORCID 0000-0003-1473-5561
Jonas N SøndergaardHuman Single Cell Immunology Team, Center for Infectious Disease Education and Research (CiDER), Osaka University, Suita, Osaka, 565-0871, Japan.ORCID 0000-0002-4438-6756
Shuhei SakakibaraLaboratory of Immune Regulation, IFReC, Osaka University, Suita, Osaka, 563-0793, Japan.ORCID 0000-0003-3157-5870
Fuminori SugiharaCore Instrumentation Facility, Immunology Frontier Research Center and Research Institute for Microbial Disease, Osaka University, Suita, Osaka, 563-0793, Japan.
Shunichiro NakaoDepartment of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Yuki TogamiDepartment of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Jumpei YoshimuraDepartment of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Hiroshi ItoDepartment of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Shinya OnishiDepartment of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Arisa MuratsuDepartment of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Yumi MitsuyamaDepartment of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Hiroshi OguraCenter for Infectious Disease Education and Research (CiDER), Osaka University, Suita, Osaka, 565-0871, Japan.
Jun OdaCenter for Infectious Disease Education and Research (CiDER), Osaka University, Suita, Osaka, 565-0871, Japan.ORCID 0000-0002-8254-3716
Daisuke OkusakiCenter for Infectious Disease Education and Research (CiDER), Osaka University, Suita, Osaka, 565-0871, Japan.ORCID 0000-0002-4552-783X
Hisatake MatsumotoCenter for Infectious Disease Education and Research (CiDER), Osaka University, Suita, Osaka, 565-0871, Japan. h-matsumoto@hp-emerg.med.osaka-u.ac.jp.
James B WingLaboratory of Human Single Cell Immunology, World Premier International Research Center Initiative Immunology Frontier Research Center (WPI-IFReC), Osaka University, Suita, Osaka, 563-0793, Japan. jbwing@ifrec.osaka-u.ac.jp.ORCID 0000-0002-3462-1003

Funding

Japan Agency for Medical Research and Development (AMED) JP223fa627002Nippon Foundation Osaka University Project for Infectious Disease PreventionTakeda Science Foundation 2021 High-Risk Emerging Infectious Disease Research Gran
6 · The paper itself

Abstract

Resting memory B cells can be divided into classical or atypical groups, but the heterogenous marker expression on activated memory B cells makes similar classification difficult. Here, by longitudinal analysis of mass cytometry and CITE-seq data from cohorts with COVID-19, bacterial sepsis, or BNT162b2 mRNA vaccine, we observe that resting B cell memory consist of classical CD45RB

Indexed as

BNT162 VaccineCOVID-19Leukocyte Common AntigensMemory B CellsSARS-CoV-2AdultAgedAntibodies, ViralB-LymphocytesCOVID-19 VaccinesFemaleHumansImmunologic MemoryMaleMiddle AgedmRNA VaccinesAntibodies, ViralBNT162 VaccineCOVID-19 VaccinesLeukocyte Common AntigensmRNA Vaccines

Identifiers

PMID39122676
PMCPMC11315995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.